Poly Medicure Limited has announced an earnings call to discuss its financial performance for the third quarter and nine months of fiscal year 2026. The company issued a formal notification to stock exchanges on January 31, 2026, informing stakeholders about the upcoming earnings discussion.

Earnings Call Details

The earnings call has been scheduled with specific timing and participation details for investors and analysts.

Management Participation

The earnings call will be represented by senior management personnel who will discuss the company's Q3FY26 performance and address stakeholder queries.

Participation Information

Poly Medicure Limited has provided multiple options for stakeholders to join the earnings discussion. The company has arranged both registration-based access and direct dial-in facilities for participants.

Access Options:

• Diamond Pass Registration Link (available through company communication)
• Universal Dial-In Numbers: +91 22 62801368, +91 22 71158269

Coordination Contact:

• Coordinator: Aayur Verma
• Mobile: +91 9873718699
• Email: aayur.verma@polymedicure.com

Regulatory Compliance

The earnings call announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification was formally communicated to both BSE Limited and National Stock Exchange of India Limited, ensuring compliance with listing obligations. Company Secretary Avinash Chandra signed the official communication on January 31, 2026, maintaining transparency with stakeholders regarding the company's financial disclosure schedule.

Poly Medicure Ltd. recorded a substantial block trade on the National Stock Exchange (NSE), marking significant institutional activity in the healthcare sector. The transaction represents one of the notable block deals executed in the mid-cap healthcare space.

Block Trade Details

The NSE block trade involved substantial volume and value, demonstrating significant institutional participation in the company's stock.

Market Significance

Block trades typically involve large institutional investors and represent significant market transactions. The execution of approximately 953,661 shares at ₹1,648.20 per share indicates substantial institutional interest in Poly Medicure's stock. Such transactions are often conducted by institutional investors, mutual funds, or other large market participants seeking to execute substantial volumes without impacting regular market trading.

Company Profile

Poly Medicure operates in the healthcare sector and is classified as a mid-cap stock. The company's stock trades on both major Indian exchanges, with the recent block trade highlighting continued institutional engagement with the healthcare sector.

The block trade execution at ₹1,648.20 per share provides insight into the institutional valuation of the company's stock and reflects the ongoing market dynamics in the healthcare sector.